1. Girelli ME, Nacamulli D, Pelizzo MR, De Vido D, Mian C, Piccolo M, et al. Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986. Thyroid. 1998. 8:517–523.
Article
2. You YN, Lakhani V, Wells SA Jr, Moley JF. Medullary thyroid cancer. Surg Oncol Clin N Am. 2006. 15:639–660.
Article
3. Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery. 2001. 130:941–946.
Article
4. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 1993. 363:458–460.
Article
5. Leboulleux S, Baudin E, Travagli JP, Schlumberger M. Medullary thyroid carcinoma. Clin Endocrinol (Oxf). 2004. 61:299–310.
Article
6. Szakáll S Jr, Esik O, Bajzik G, Repa I, Dabasi G, Sinkovics I, et al. 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma. J Nucl Med. 2002. 43:66–71.
7. Giraudet AL, Vanel D, Leboulleux S, Aupérin A, Dromain C, Chami L, et al. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab. 2007. 92:4185–4190.
Article
8. Adams S, Baum R, Rink T, Schumm-Dräger PM, Usadel KH, Hör G. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med. 1998. 25:79–83.
Article
9. Frilling A, Becker H, Roeher HD. Unusual features of multiple endocrine neoplasia. Henry Ford Hosp Med J. 1992. 40:253–255.
10. Nishimura Y, Yamashita K, Yumita W, Yamazaki M, Katai M, Sakurai A, et al. Multiple endocrine neoplasia type 1 with unusual concomitance of various neoplastic disorders. Endocr J. 2004. 51:75–81.
Article